NPAT anticorps (Middle Region)
Aperçu rapide pour NPAT anticorps (Middle Region) (ABIN5673429)
Antigène
Voir toutes NPAT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Séquence
- TPPEGTPVEN SHSLPPESVC SSVGDSHPES QNTDDKPSSN NSAEIDASNI
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human NPAT
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- NPAT (Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT))
-
Autre désignation
- NPAT
-
Sujet
-
Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters.
Alias Symbols: E14, p220, E14/NPAT
Protein Size: 1427 -
ID gène
- 4863
-
NCBI Accession
- NM_002519, NP_002510
-
UniProt
- Q14207
Antigène
-